Price movement over the last 24 hours
Agilent Technologies Inc vs WD 40 Company — how do they compare? Agilent Technologies Inc trades at $128.33 (market cap $37.04B), while WD 40 Company trades at $243.18 (market cap $3.36B). The key difference: Agilent Technologies Inc is far larger — about 11× WD 40 Company's market cap, and WD 40 Company pays the higher dividend (1.63%). Which is the better fit depends on your goals.
| A | WDFC | |
|---|---|---|
Market Cap | $37.04B | $3.36B |
Sector | Health | Technology |
52-Week High | $157.20 | $252.96 |
52-Week Low | $110.24 | $187.52 |
Enterprise Value | $38.59B | $3.42B |
Dividend Yield | 0.78% | 1.63% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
WDFC trades at $246.45, up 0.25% with a bullish technical outlook supported by moving averages. The company maintains strong profitability with 55.67% gross margins and recently beat Q1 2026 earnings expectations. Recent corporate developments include executive leadership appointments and a $1.02 quarterly dividend declaration. Revenue growth remains steady with 2026 projections at $636 million, though net income is expected to decline to $80 million.
WDFC presents a mixed investment case with premium valuation metrics (P/E 41.82) offset by consistent profitability and dividend payments. The primary risk involves earnings volatility as seen in recent quarterly misses, while analyst sentiment remains cautious with 71% hold ratings. Upside potential exists if the company can maintain its recent earnings beat trend and execute on growth initiatives.
Trailing returns across standard periods
Latest headlines on both assets
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →WD-40 Company is a global marketing organization dedicated to creating 'positive lasting memories' by developing and selling products that solve maintenance and cleaning problems. Built around the legendary WD-40 Multi-Use Product, the company operates an asset-light business model, focusing on brand management and innovation while utilizing a network of contract manufacturers to deliver solutions across the Americas, EIMEA, and Asia-Pacific.
Read more on WDFC →